Avita Medical Net Worth
Avita Medical Net Worth Breakdown | RCEL |
Avita Medical Net Worth Analysis
Avita Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Avita Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Avita Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Avita Medical's net worth analysis. One common approach is to calculate Avita Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Avita Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Avita Medical's net worth. This approach calculates the present value of Avita Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Avita Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Avita Medical's net worth. This involves comparing Avita Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Avita Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Avita Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Avita Medical's net worth research are outlined below:
| Avita Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 50.14 M. Net Loss for the year was (35.38 M) with profit before overhead, payroll, taxes, and interest of 28.38 M. | |
| Avita Medical currently holds about 84.17 M in cash with (38.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.67. | |
| Avita Medical has a poor financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: AVITA Medicals SWOT analysis regenerative medicine firms stock faces growth hurdles |
Avita Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Avita Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Avita Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Avita Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Avita Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avita Medical backward and forwards among themselves. Avita Medical's institutional investor refers to the entity that pools money to purchase Avita Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2024-09-30 | 70.9 K | Jane Street Group Llc | 2024-06-30 | 67.4 K | D. E. Shaw & Co Lp | 2024-09-30 | 67.1 K | Bank Of New York Mellon Corp | 2024-09-30 | 53.1 K | Ameriprise Financial Inc | 2024-09-30 | 44.3 K | Curi Rmb Capital | 2024-09-30 | 43 K | Bank Of America Corp | 2024-06-30 | 41 K | Barclays Plc | 2024-09-30 | 37.5 K | Rhumbline Advisers | 2024-09-30 | 34.4 K | Blackrock Inc | 2024-06-30 | 1.8 M | Vanguard Group Inc | 2024-09-30 | 1.4 M |
Follow Avita Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 336.9 M.Market Cap |
|
Project Avita Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.31) | (0.33) | |
| Return On Capital Employed | (0.36) | (0.38) | |
| Return On Assets | (0.31) | (0.33) | |
| Return On Equity | (0.36) | (0.38) |
When accessing Avita Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Avita Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Avita Medical's profitability and make more informed investment decisions.
Evaluate Avita Medical's management efficiency
Avita Medical has return on total asset (ROA) of (0.4537) % which means that it has lost $0.4537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5244) %, meaning that it created substantial loss on money invested by shareholders. Avita Medical's management efficiency ratios could be used to measure how well Avita Medical manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.33. The value of Return On Capital Employed is expected to slide to -0.38. At this time, Avita Medical's Net Current Asset Value is quite stable compared to the past year. Tangible Asset Value is expected to rise to about 4.1 M this year, although the value of Intangible Assets will most likely fall to about 462.6 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.73 | 5.44 | |
| Net Current Asset Value | 2.2 M | 2.9 M | |
| Tangible Asset Value | 2.4 M | 4.1 M | |
| Tangible Book Value Per Share | 5.69 | 5.41 | |
| Enterprise Value Over EBITDA | (4.03) | (4.23) | |
| Price Book Value Ratio | 1.19 | 1.13 | |
| Enterprise Value Multiple | (4.03) | (4.23) | |
| Price Fair Value | 1.19 | 1.13 | |
| Enterprise Value | 124.9 M | 131.1 M |
Avita Medical benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue 5.6184 | Revenue 60 M | Quarterly Revenue Growth 0.432 | Revenue Per Share 2.335 | Return On Equity (1.52) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avita Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avita Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avita Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Avita Medical Corporate Filings
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 20th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 3rd of July 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 23rd of April 2024 Other Reports | ViewVerify |
Avita Medical Earnings per Share Projection vs Actual
Avita Medical Corporate Management
| Rob Hall | Senior Resources | Profile | |
| Michael MBA | Chief Officer | Profile | |
| Jessica Ekeberg | Investor Executive | Profile | |
| David OToole | Chief Officer | Profile | |
| Kathy McGee | Chief Officer | Profile | |
| Terry Bromley | Senior Sales | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.23) | Revenue Per Share 2.335 | Quarterly Revenue Growth 0.432 | Return On Assets (0.45) | Return On Equity (1.52) |
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.